Talking to your doctor

One of the best steps you can take in better understanding your ADHD treatment options is having an open and honest conversation with your doctor.

Preparing for the conversation  

The Qelbree Doctor
Discussion Guide  

Non-stimulant Qelbree  

Qelbree samples  

A good conversation starts with even better preparation

Doctor appointments are an opportunity for you and your doctor to connect on your treatment plan and overall ADHD management. But they can also be a bit overwhelming, and can be over before you realize it.

It can be easy to forget things you wanted to discuss when walking into your doctor’s office, so a bit of planning ahead can go a long way.

Here are some key topics to focus on before you attend your next appointment:

ADHD Impact

  • How has ADHD impacted your life since your last appointment?
  • Has anything changed?

ADHD Treatment

  • If you’re on treatment, do you feel like it’s helping?
  • Are there parts of your current treatment that you’d like to change?
  • Would a non-stimulant treatment be appropriate for me?

ADHD Goals

  • What do you most want to see change about your experience with ADHD?
  • Is there more you would like out of treatment?

Preparing for the conversation  

The Qelbree Doctor
Discussion Guide  

Non-stimulant Qelbree  

Qelbree samples  

The Qelbree Doctor Discussion Guide can help

To help you better prepare to have a productive conversation with your doctor, the Qelbree Doctor Discussion Guide helps you identify core topics for discussion before your next appointment.

You can save your results and have them at the ready when you step in the office for your next visit.

Start your Qelbree Doctor Discussion Guide

The partnership I have with my doctor is

invaluable

.

Preparing for the conversation  

The Qelbree Doctor
Discussion Guide  

Non-stimulant Qelbree  

Qelbree samples  

Talking to your doctor about non-stimulant Qelbree

Qelbree is the first non-stimulant approved for adult ADHD in over 20 years and could be an option to treat your ADHD.

Qelbree Works

Qelbree has been shown to significantly reduce the symptoms of ADHD in a clinical trial

Qelbree is not a controlled substance

Qelbree shows no evidence of abuse or misuse, and is unlikely to have negative interactions with commonly used stimulants

Qelbree can fit your schedule

Qelbree can be taken once a day with or without food at any time and may be available for 90-day refills without additional doctor appointments

Change can be a good thing

In fact, most patients taking Qelbree were prescribed Qelbree because their previous ADHD treatment plan needed a change.

Learn more  

Preparing for the conversation  

The Qelbree Doctor
Discussion Guide  

Non-stimulant Qelbree  

Qelbree samples  

Already diagnosed or think you may have ADHD?

Starting a new medication can be an important step towards managing your ADHD. Your doctor may have samples of Qelbree available at your next appointment to help you get started.

Contact your doctor to set up an in-person or telemedicine appointment to request a sample of Qelbree.

Back to top  

Savings and
Resources

Learn more about the resources available to you with Qelbree.

Get Resources  

IMPORTANT SAFETY INFORMATION ABOUT QELBREE

INDICATION

Qelbree® (viloxazine extended-release capsules) is a prescription medicine used to treat ADHD in adults and children 6 years and older.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment [read more] or when the dose is changed. Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment or when the dose is changed. [read more] Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

You should not take Qelbree if you or your child:
Take a medicine for depression called a monoamine oxidase inhibitor (MAOI) or have stopped taking an MAOI in the past 14 days. Also, you or your child should avoid alosetron, duloxetine, ramelteon, tasimelteon, tizanidine, and theophylline.

Qelbree can increase blood pressure and heart rate. Your or your child’s doctor will monitor these vital signs.

Qelbree may cause manic episodes in patients with bipolar disorder. Tell your doctor if you or your child show any signs of mania.

Do not drive or operate heavy machinery until you know how Qelbree will affect you or your child. Qelbree may cause you or your child to feel sleepy or tired.

The most common side effects of Qelbree in patients 6 to 17 years are sleepiness, not feeling hungry, feeling tired, nausea, vomiting, trouble sleeping, and irritability, and in adults, insomnia, headache, sleepiness, tiredness, nausea, decreased appetite, dry mouth, and constipation. These are not all the possible side effects of Qelbree.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Medication Guide including Boxed Warning.

IMPORTANT SAFETY INFORMATION ABOUT QELBREE

INDICATION

Qelbree® (viloxazine extended-release capsules) is a prescription medicine used to treat ADHD in adults and children 6 years and older.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment [read more] or when the dose is changed. Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment or when the dose is changed. [read more] Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

You should not take Qelbree if you or your child:
Take a medicine for depression called a monoamine oxidase inhibitor (MAOI) or have stopped taking an MAOI in the past 14 days. Also, you or your child should avoid alosetron, duloxetine, ramelteon, tasimelteon, tizanidine, and theophylline.

Qelbree can increase blood pressure and heart rate. Your or your child’s doctor will monitor these vital signs.

Qelbree may cause manic episodes in patients with bipolar disorder. Tell your doctor if you or your child show any signs of mania.

Do not drive or operate heavy machinery until you know how Qelbree will affect you or your child. Qelbree may cause you or your child to feel sleepy or tired.

The most common side effects of Qelbree in patients 6 to 17 years are sleepiness, not feeling hungry, feeling tired, nausea, vomiting, trouble sleeping, and irritability, and in adults, insomnia, headache, sleepiness, tiredness, nausea, decreased appetite, dry mouth, and constipation. These are not all the possible side effects of Qelbree.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Medication Guide including Boxed Warning.